Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.

Trimarco, B

Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. [electronic resource] - Archives internationales de pharmacodynamie et de therapie Dec 1980 - 251-9 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial

0003-9780


Arrhythmias, Cardiac--drug therapy
Clinical Trials as Topic
Disopyramide--adverse effects
Electrocardiography
Humans
Lidocaine--therapeutic use
Mexiletine--adverse effects
Propylamines--therapeutic use
Pyridines--therapeutic use
Random Allocation